Sumitomo Mitsui Trust Holdings, Inc. Surface Oncology, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.61 - $1.03 $44,522 - $75,176	-72,987 Reduced 6.81%	999,026 $699,000
Q4 2022 Jan 30, 2023	SELL	$0.62 - $1.21 $19,974 - $38,982	-32,217 Reduced 2.92%	1,072,013 $879,000
Q3 2022 Oct 21, 2022	BUY	$1.05 - $2.1 $1.16 Million - $2.32 Million	1,104,230 New	1,104,230 $1.15 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.